MS decreases the larger amplitude distribution in adult rats. by Jesús David Ayala-Rodríguez (17364296)

Matrix crosslinking decreases cell migration persistence. by Michael Pamonag (12295175)

A noxious temperature decrease without a prior increase produces a subtly larger decrease in pain intensity. by Benedict J. Alter (9745466)

Correlations of cytokines that significantly change between the pre-infusion and post-infusion blood draws pearson’s correlation between cytokine pairs is indicated by color and si... by Jordan K. Abbott (8934239)

Subjects:

Larger example of stimuli with cue relevant for Task 3. by Marcel F. Hinss (14675457)

Long COVID prevalence decreases with vaccine uptake in the U.S. by Manlio De Domenico (626037)

“…<p>(A) Prevalence in U.S. states and the U.S. exhibits a decreasing trend with respect to vaccine uptake, both in the population vaccinated with at least one dose (top) and two doses (bottom), with the largest gap between 100% vaccinated and 100% unvaccinated scenarios observed in the reference population of adults who had COVID-19. …”

Points represent regions where the cluster coefficient was significantly larger in HC compared to MCI, at sparsity level of 0.15. by Therese M. Gilligan (7460906)

Decrease of injuries. by Petr Fulin (8380320)

Subjects:

Example of predicted effects of choice bundling on preference for larger, later rewards (LLRs) over smaller, sooner rewards (SSRs). by Jeffrey S. Stein (11689918)

Decrease of admissions and lead diagnoses. by Petr Fulin (8380320)

Subjects:

Adverse events. by Måns Stefansson (17054666)

Sensitivity analyses of seroprevalence with the largest sample size study omitted. by Yu Zhou (89766)

Significant relationships between QOL measures on infusion day and day 7. by Jordan K. Abbott (8934239)

Subjects:

Phase 2 significant effects. by Wendy C. Crone (2262169)

Phase 1 significant effects. by Wendy C. Crone (2262169)

Adverse events in the included studies. by Kazushi Uneda (468948)

Subjects:

Table1_Potentially clinically significant drug-drug interactions in older patients admitted to the hospital: A cross-sectional study.pdf by Zuzana Očovská (12864617)

“…Our objective was to describe the prevalence and characteristics of drug combinations potentially causing clinically significant DDIs identified in the medication history of older patients admitted to the hospital and the prevalence and characteristics of manifest DDIs–DDIs involved in adverse drug events present at hospital admission, DDIs that contributed to ADE-related hospital admissions, and DDIs involved in drug-related laboratory deviations.…”

Anesthesia-related adverse events. by Markus Zadrazil (13267697)

Association between childhood adversities and rate of hospitalizations. by Asmita Bhattarai (7352540)

Subjects:

Clinical characteristics of glofitamab-associated adverse event reports. by Meng Zhou (105903)

Subjects: